Anti DKK3 pAb (ATL-HPA011868 w/enhanced validation)

Atlas Antibodies

SKU: ATL-HPA011868-25

• 
• 
• 

Protein Description: dickkopf WNT signaling pathway inhibitor 3
Gene Name: DKK3
Alternative Gene Name: REIC, RIG
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000030772: 83%, ENSRNOG00000016343: 81%
Entrez Gene ID: 27122
Uniprot ID: Q9UBP4
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Product Specifications

• Application: WB, ICC, IHC
• Reactivity: Human
• Clonality: Polyclonal
• Host: Rabbit
• Immunogen: CGDQLCVWGHCTKMATRGSNGTICDNQRDCQPGLCCAFQRGLLFPVCTPLPVEGELCHDPASRLLDLITWELEPDGALDRCPCASGLLCQPHSHSLVYVCKPTFVGSRDQDGEILLPREVPDEYLAASW
• Gene Sequence: CGDQLCVWGHCTKMATRGSNGTICDNQRDCQPGLCCAFQRGLLFPVCTPLPVEGELCHDPASRLLDLITWELEPDGALDRCPCASGLLCQPHSHSLVYVCKPTFVGSRDQDGEILLPREVPDEYLAASW
• Gene ID - Mouse: ENSMUSG00000030772
• Gene ID - Rat: ENSRNOG00000016343
• Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.

Citations for Anti DKK3 pAb (ATL-HPA011868 w/enhanced validation) – 2 Found

Ferrari, Nicola; Ranftl, Romana; Chicherova, Ievgeniia; Slaven, Neil D; Moeendarbary, Emad; Farrugia, Aaron J; Lam, Maxine; Semiannikova, Maria; Westergaard, Marie C W; Tchou, Julia; Magnani, Luca; Calvo, Fernando. Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts. Nature Communications. 2019;10(1):130. 

Rivellese, Felice; Surace, Anna E A; Goldmann, Katriona; Sciacca, Elisabetta; Çubuk, Cankut; Giorli, Giovanni; John, Christopher R; Nerviani, Alessandra; Fossati-Jimack, Liliane; Thorborn, Georgina; Ahmed, Manzoor; Prediletto, Edoardo; Church, Sarah E; Hudson, Briana M; Warren, Sarah E; McKeigue, Paul M; Humby, Frances; Bombardieri, Michele; Barnes, Michael R; Lewis, Myles J; Pitzalis, Costantino. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. Nature Medicine. 2022;28(6):1256-1268.